Wilson's disease
ICD-10 E83.0 · ICD-11 5C64.00

Neurological Symptoms of Wilson's Disease: What to Do When First-Line Therapy Has Not Worked

Clinical Scenario

This protocol applies to patients with neurological symptoms of Wilson's disease in whom the initial management strategy — reducing chelator doses, slowing dose escalation, and discontinuing dopamine receptor antagonists — did not achieve the expected therapeutic goals.

First-Line Goals That Were Not Reached

The first-line approach aimed at resolving paradoxical neurological worsening and achieving progressive improvement in neurological symptoms with a decrease or normalisation of the UWDRS score. Failure to reach these endpoints is the trigger for escalation to this next protocol step.

Next Step: Treatment Switch

This protocol involves switching the Wilson's disease treatment regimen. A change in treatment class is central to the approach, with second-line options available. The complete switching algorithm — which agents, in what order, and under what conditions — is available in the full protocol.

Treatment Goals

The target is progressive improvement of neurological symptoms, with decrease or normalisation of the UWDRS score as the primary measurable endpoint of treatment response.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jhep.2024.11.007

View source ↗